Upgrade to SI Premium - Free Trial

Amphastar Pharma (AMPH)

26.04 -0.16 (0.61%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Form 4 Amphastar Pharmaceutical For: Sep 21 Filed by: PETERS WILLIAM J September 23, 2026 6:03 PM - SEC Filing Form 144 Amphastar Pharmaceutical Filed by: PETERS WILLIAM J September 21, 2026 6:38 PM - SEC Filing Amphastar Pharma (AMPH) 6300 contracts of October calls trade September 21, 2026 2:11 PM - StreetInsider Form 4 Amphastar Pharmaceutical For: Sep 16 Filed by: Zhou Rong September 17, 2026 6:20 PM - SEC Filing Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Barclays August 19, 2026 3:21 AM - StreetInsider Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F. August 18, 2026 5:57 PM - SEC Filing Form 4 Amphastar Pharmaceutical For: Aug 11 Filed by: PRINS RICHARD K August 12, 2026 6:15 PM - SEC Filing Form 4 Amphastar Pharmaceutical For: Aug 07 Filed by: PETERS WILLIAM J August 11, 2026 4:57 PM - SEC Filing Form 144 Amphastar Pharmaceutical Filed by: PRINS RICHARD K August 11, 2026 11:54 AM - SEC Filing Form 144 Amphastar Pharmaceutical Filed by: PETERS WILLIAM J August 7, 2026 4:11 PM - SEC Filing Amphastar Pharmaceuticals (AMPH) PT Raised to $20 at Wells Fargo August 7, 2026 8:20 AM - StreetInsider Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Piper Sandler August 7, 2026 7:48 AM - StreetInsider Amphastar Pharma (AMPH) Tops Q2 EPS by 28c August 7, 2026 2:31 AM - StreetInsider Form 10-Q Amphastar Pharmaceutical For: Jun 30 August 6, 2026 4:51 PM - SEC Filing Form 8-K Amphastar Pharmaceutical For: Aug 06 August 6, 2026 4:37 PM - SEC Filing Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 August 6, 2026 4:05 PM - PR NewsWire Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 July 29, 2026 6:00 AM - PR NewsWire Full Article List